Experimental Drug Shows 'Modest' Benefit in Slowing Advanced Breast Cancer

SATURDAY, June 2, 2018 — A new and highly targeted drug slowed the growth of advanced breast cancers by about an average of two months, researchers report.
“The findings in this study show a modest benefit to a subgroup of women with estrogen…
Source: Topamax